These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Effectiveness of intravenous immunoglobulins in polymyositis and dermatomyositis. An open trial in 15 patients]. Cherin P, Herson S, Wechsler B, Piette JC, Bletry O, Degennes C, Ziza JM, Du LT, Godeau P. Presse Med; 1991 Feb 16; 20(6):244-9. PubMed ID: 1706860 [Abstract] [Full Text] [Related]
5. Intravenous immunoglobulin therapy for refractory myositis. Moriguchi M, Suzuki T, Tateishi M, Hara M, Kashiwazaki S. Intern Med; 1996 Aug 16; 35(8):663-7. PubMed ID: 8894745 [Abstract] [Full Text] [Related]
6. WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis. Choy EH, Hoogendijk JE, Lecky B, Winer JB, Gordon P. Cochrane Database Syst Rev; 2009 Oct 07; (4):CD003643. PubMed ID: 19821312 [Abstract] [Full Text] [Related]
9. [Immunoglobulins or plasma exchange? New treatment methods in polymyositis and dermatomyositis: plasma exchange and intravenous immunoglobulins]. Chérin P, Herson S. Ann Med Interne (Paris); 1993 Oct 07; 144(8):521-5. PubMed ID: 8179241 [Abstract] [Full Text] [Related]
15. Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis. Dalakas MC. Neurology; 1998 Dec 07; 51(6 Suppl 5):S37-45. PubMed ID: 9851729 [Abstract] [Full Text] [Related]